New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
The non-dilutive financing includes three tranches
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Miravo to remain a Canadian controlled and operated company following closing of the transaction
RxDx is a chain of primary care driven multispecialty healthcare clinics with two main branches situated in Whitefield and Malleswaram in Bengaluru
Subscribe To Our Newsletter & Stay Updated
